New immunotherapy platform has increased potential to target cancer cells
Researchers from Children's Hospital of Philadelphia (CHOP) and Stanford University have revealed the molecular structure of TRACeR-I, a protein platform for reprogramming immune responses.
2 hours ago
0
0